Product Code: PHM274A
Highlights:
The global veterinary vaccines market reached $9.1 billion in 2022, should reach $9.6 billion by 2023 and $14.2 billion by 2028 with a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2023-2028.
Livestock segment of the global veterinary vaccines market reached $3.9 billion in 2022, should reach $4.1 billion by 2023 and $6.1 billion by 2028 with a CAGR of 8.3% during the forecast period of 2023-2028.
Companion animals segment of the global veterinary vaccines market reached $815.1 million in 2022, should reach $857.3 million by 2023 and $1.3 billion by 2028 with a CAGR of 9.4% during the forecast period of 2023-2028.
Report Scope:
This report aims to provide a comprehensive study of the global market for veterinary vaccines. It describes the different types of veterinary vaccines products, technology, and their current and historical market revenues.
Veterinary vaccines include designs and different technology along with applications. The product of veterinary vaccines are segmented into attenuated vaccine (live vaccine, modified live vaccine, live attenuated vaccine), inactivated vaccine, recombinant vaccine (subunit vaccine, polysaccharide vaccine, conjugate vaccine, chimeric vaccine, viral-vector vaccine), and toxoid vaccine.
This report also covers a detailed study of animal species in the veterinary vaccines market, including livestock, poultry, companion animals, swine, equine, and others (aquaculture, etc.) An in-depth analysis of the global market for veterinary vaccines includes historical data and market projections on sales by technology/system type, product, application, design, and region.
For an in-depth understanding of the market, profiles of market participants, essential marketed products, competitive landscape, key competitors, ESG analysis, and their respective market shares have been provided. This report also discusses the driving and restraining factors of the global veterinary vaccines market.
Report Includes:
- 145 data tables and 45 additional tables
- A comprehensive overview of the current and future global markets for veterinary vaccines
- Analyses of the global market trends, with historic market revenue data (sales figures) for 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
- Estimation of the actual market size and revenue forecast for global veterinary vaccines market in USD millions, and corresponding market share analysis based on the product, type of attenuated and recombinant vaccines, animal type, route of administration, and region
- Highlights of upcoming market opportunities and trends driving and restricting growth of global veterinary vaccines market and its sub-segments, and major regions and countries involved in the market developments
- In-depth information (facts and figures) concerning major market dynamics (DROs), technology advancements, regulatory aspects, and various macroeconomics factors influencing the demand and progress of this market
- Country specific data and market value analysis for the U.S., Canada, Mexico, Germany, France, Italy, Spain, the UK, Japan, China, India, Australia and New Zealand (ANZ), Brazil, Argentina, South Africa, and GCC countries, among others
- Information about ESG-related developments in the animal health industry, key issues, implementation strategies, and analyses of factors affecting ESG applications in the market
- Identification of the companies engaged in research and development (R&D) of vaccination and vaccine production, emerging technologies, and a SWOT analysis of leading competitors and their market penetration
- Company profiles of major players within the industry, including Boehringer Ingelheim, Dechra, Elanco, Merck & Co. Inc., and Zoetis Services LLC
Table of Contents
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst's Credentials
- BCC Custom Research
- Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
- Overview of Veterinary Vaccines
- Animal Types and Vaccination
- Livestock
- Companion Animals
- Equine Animals
- Swine
- Poultry
- Other Animals
- Vaccines and Veterinary Products Export
- Trends in Animal Healthcare
- Growing Demand for Animal Health Products
Chapter 4 Market Dynamics
- Market Dynamics
- Drivers
- Incidence and Prevalence of Animal Disease
- Global Warming and Impact on Veterinary Animals
- Increase in Investment for Treating and Eradicating Diseases in Animals
- Emergence of Zoonotic Diseases
- Rise in Awareness Programs on Veterinary Vaccines
- Vaccines and Food Production
- Restraints
- Product Development and Manufacturing Challenges
- Side Effects of Vaccination
- Financial Prioritization and Herd Immunity Risk
- Other Restraints
- Opportunities
- Launch of New Veterinary Vaccines
- Reducing the Need for Antibiotics
- Funding for Innovative Veterinary Vaccines and Services
Chapter 5 Impact of COVID-19 on Animal Health and Production Facilities
- Overview
- Short-Term Impact
- Long-Term Impact
- COVID-19 Impact on Animal Welfare
- Animal Disease Management
- Vaccination Campaigns
Chapter 6 Emerging Technologies in Veterinary Vaccines
- Overview
- Multivalent Veterinary Vaccines
- mRNA Vaccine
- Pipeline Analysis of Animal Vaccines
Chapter 7 Global Market for Veterinary Vaccines, by Product
- Introduction
- Attenuated Vaccine
- Inactivated Vaccine
- Toxoid Vaccines
- Recombinant Vaccine
Chapter 8 Global Market for Veterinary Vaccines, by Type of Animal
- Overview
- Market Outlook
- Livestock
- Poultry
- Companion Animals
- Swine
- Equine
- Other Animals
Chapter 9 Global Market for Veterinary Vaccines, by Administration
- Global Market for Veterinary Vaccines by Administration
- Subcutaneous Route of Administration
- Intramuscular Route of Administration
- Intranasal Route of Administration
- Oral Route of Administration
Chapter 10 Global Market for Veterinary Vaccines, by Region
- Global Markets for Veterinary Vaccines by Region
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- Italy
- France
- United Kingdom
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- India
- Australia and New Zealand
- China
- Rest of Asia-Pacific
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East & Africa
Chapter 11 Competitive Landscape
- Global Analysis of Company Shares
- SWOT Analysis
Chapter 12 M&A and Funding Outlook
- M&A Analysis
- Fundings in Animal Healthcare
Chapter 13 Sustainability of the Animal Health Industry: An ESG Perspective
- Overview of ESG
- Key ESG Issues in the Animal Healthcare Industry
- Animal Health Industry ESG Performance Analysis
Chapter 14 Company Profiles
- ARKO LABORATORIES
- AVIMEX
- BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- CEVA SANTE ANIMALE (CEVA)
- DECHRA PHARMACEUTICALS.
- ELANCO.
- MERCK & CO. INC.
- PHIBRO ANIMAL HEALTH CORP.
- VIRBAC
- ZOETIS SERVICES LLC.